Pharma Equity Group A/S (CPSE: PEG)
Health Care · Pharmaceuticals · DK
Dkr0.08
-2.06% today · -23.8% 1Y
Pharma Equity Group A/S (CPSE: PEG) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $14.01M and employs 5 people.
Over the last twelve months the share price has lost 23.8%, trading between 0.06 and 0.12.
Tweenvest scores Pharma Equity Group A/S across four factors: quality 52/100, value 31/100. Its strongest factor is quality.
PEG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.01M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.06
- 52-week high
- Dkr0.12
- 52-week low
- Dkr0.06
- Avg volume (3M)
- —
- Shares outstanding
- 1.23B
- Employees
- 5
- Next earnings
- —
About Pharma Equity Group A/S
Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which the current therapy is lacking or in need of improvement. Its products under development, includes RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouchitis; and RNX-051 for the treatment of colorectal cancer and colon adenoma that are in Phase II clinical trials. The company was incorporated in 2002 and is headquartered in Horsholm, Denmark.
- ISIN
- DK0061155009
- Founded
- 2002
- Listed since
- May 16, 2023
- Exchange
- OMX Nordic Exchange Copenhagen
- Currency
- DKK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bio Essence CorporationOTCPK: BIOE | $14.37M | $0.27 | — |
| Lobe Sciences Ltd.CNSX: LOBE | $14.28M | CA$0.06 | +9.09% |
| Lipocine Inc.NasdaqCM: LPCN | $14.18M | $1.69 | -1.74% |
| Panchsheel Organics LimitedBSE: 531726 | $14.04M | Rs103.15 | +0.29% |
| Parnax Lab LimitedBSE: 506128 | $13.89M | Rs117.00 | +1.74% |
| Biotika a.s.BSSE: 1BSL01AE | $13.81M | €— | — |
| Yi Po International Holding LimitedOTCPK: YBZN | $13.77M | $— | — |
| Tvardi Therapeutics, Inc.NasdaqCM: TVRD | $13.74M | $1.03 | 0.00% |
Figures last refreshed Oct 11, 2026.